Clinical trials and real-world data consistently show: Average weight loss of 1520% on semaglutide or tirzepatide Improvements in blood pressure, cholesterol, and blood sugar Reduced risk of developing type 2 diabetes and cardiovascular disease These outcomes are meaningful both for employee health and long-term cost avoidance
Note that each of these methods carries accuracy and safety risks and manufacturers strongly advise against this due to the risk of inaccurate dosing and medication waste
Business Type Exporter, Importer, Manufacturer, Supplier, Wholesaler, Dealer Employee Count 40 Establishment 2012 Working Days To GST NO 27ATQPP1847D1ZE Payment Mode Online Payments (NEFT/RTGS/IMPS), Cheque/DD, Wallet & UPI Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27ATQPP1847D1ZE Trusted Seller Mumbai, Maharashtra Proprietor Mr Dipesh P Chhajed Members since 9 Years Address 20, Broadway Shopping Centre, Dr B.A Road, Dadar T.T, Mumbai, Maharashtra, 400014, India pharmaceutical injection in Mumbai Report incorrect details
Semaglutide (Wegovy) hits one
Lau J, Bloch P, Schffer L, Pettersson I, Spetzler J, Kofoed J, et al